|1.||Bosland, Maarten C: 1 article (02/2002)|
|2.||Cavalieri, Ercole L: 1 article (02/2002)|
|3.||Devanesan, Prabu: 1 article (02/2002)|
|4.||Badawi, Alaa F: 1 article (02/2002)|
|5.||Rogan, Eleanor G: 1 article (02/2002)|
|6.||Todorovic, R: 1 article (08/2001)|
|7.||Higginbotham, S: 1 article (08/2001)|
|8.||Kumar, S: 1 article (08/2001)|
|9.||Badawi, A F: 1 article (08/2001)|
|10.||Cavalieri, E L: 1 article (08/2001)|
08/01/2001 - "Thus, formation of depurinating DNA adducts by CE-3,4-Q may be the first critical event in the initiation of estrogen-induced kidney tumors."
02/01/2002 - "These results suggest that prostate areas susceptible to carcinoma induction have less protection by COMT, GSH, and quinone reductase and/or cytochrome P450 reductase, favoring reaction of CE-3,4-Q with DNA, presumably to initiate cancer."
02/01/2002 - "To avoid cancer initiation, CE can be detoxified by catechol-O-methyltransferase (COMT), and CE-3,4-Q by conjugation with glutathione (GSH) or by reduction to CE, catalyzed by quinone reductase and/or cytochrome P450 reductase. "
|2.||NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)
|3.||NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)
|4.||Glutathione (Reduced Glutathione)
|6.||DNA (Deoxyribonucleic Acid)
|7.||Catechol O-Methyltransferase (Methyltransferase, Catechol)